Regulatory & Legal

As RSNs crumble, the St. Louis Cardinals and Gray Media launch a massive free TV package, bringing MLB and minor league games to fans across the Midwest.

SPJIMR's globally accredited PGPDM program welcomes a diverse new cohort, poised to tackle India's most pressing social and economic challenges.

A vibrant cultural showcase in Ethiopia highlights China's strategy to deepen Africa ties through soft power, moving beyond economics to win hearts and minds.

With over $10M in new funding, Berlin Heals is advancing a novel implant that uses a gentle electrical field to potentially reverse heart failure damage.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

A potential first therapy for Charcot-Marie-Tooth disease heads to a major conference, showing promising functional gains despite missing its primary goal.

A new report shows 40% of ANZ firms never assess skin cancer risk, despite 84% seeing it as a duty of care, exposing a massive legal and health liability.

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

A bipartisan federal investigation will scrutinize university and government responses to a historic surge in antisemitism on college campuses since Oct. 7.

Vynleads launches its Done With Diabetes app, using AI for daily support. But can it stand out in a crowded market and reverse its financial fortunes?

The Investment Company Institute is linking its industry to America's 250th birthday. Is it a genuine celebration or a strategic rebrand?

Maureen Keough takes the helm at Solstice Environmental, bringing diverse tech and energy expertise to steer the firm through a new era of strategic growth.

Facing a national crisis of long waits for autism diagnosis, a new free online tool from Catalight hopes to connect families with care in days, not months.

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

As Jonathan and Jason Morgan become co-CEOs, the multifamily giant eyes further growth with a new C-suite and a powerful capital deployment strategy.